Surgical & Medical Instruments & Apparatus
Standard Industrial Classification: SIC 3841
Industry Insider Sentiment Analysis
The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2013-03-15 00:55 | 2013-03-13 | MRIC | ClearPoint Neuro, Inc. | Conway Bruce C. | Director | BUY | $1.50 | 2,000 | $3,000 | 2,030,933 |
| 2013-03-13 22:33 | 2013-03-12 | ANGO | Angiodynamics Inc. | BUCCI VINCENT | Director | BUY | $10.77 | 85,000 | $915,799 | 13,000 |
| 2013-03-14 00:18 | 2013-03-11 | GMED | GLOBUS MEDICAL INC | Demski David M | Director, Officer | SELL | $15.00 | 14,225 | $213,375 | 801,365 |
| 2013-03-14 00:14 | 2013-03-12 | ANIK | Anika Therapeutics Inc. | LAND RAYMOND J | Director | SELL | $14.00 | 2,200 | $30,800 | 20,719 |
| 2013-03-13 17:26 | 2013-03-11 | LMAT | LEMAITRE VASCULAR INC | Thorndike William N Jr | Director | SELL | $6.00 | 5,878 | $35,269 | 5,051 |
| 2013-03-14 03:31 | 2013-03-11 | DXCM | DEXCOM INC | LISTER JOHN | Officer | SELL | $15.75 | 4,500 | $70,875 | 85,710 |
| 2013-03-14 02:20 | 2013-03-11 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | Officer | SELL | $15.63 | 5,100 | $79,699 | 97,312 |
| 2013-03-14 02:15 | 2013-03-13 | DXCM | DEXCOM INC | Balo Andrew K | Officer | OPT+S | $16.53 | 15,416 | $254,814 | 144,571 |
| 2013-03-13 20:41 | 2013-03-13 | MELA | STRATA Skin Sciences, Inc. | Gulfo Joseph V | Director, Officer | BUY | $1.15 | 20,000 | $22,974 | 183,311 |
| 2013-03-12 23:05 | 2013-03-06 | PDEX | PRO DEX INC | CABILLOT RAYMOND E | Director | BUY | $2.00 | 25,560 | $51,120 | 194,390 |
| 2013-03-13 00:30 | 2013-03-11 | MRIC | ClearPoint Neuro, Inc. | Conway Bruce C. | Director | BUY | $1.54 | 28,550 | $43,904 | 10,000 |
| 2013-03-13 01:05 | 2013-03-12 | ANGO | Angiodynamics Inc. | Meteny Dennis S | Director | BUY | $10.82 | 4,600 | $49,772 | 21,950 |
| 2013-03-13 02:42 | 2013-03-08 | DXCM | DEXCOM INC | VALDES JORGE A | Officer | SELL | $16.22 | 24,054 | $390,197 | 200,890 |
| 2013-03-12 00:59 | 2013-03-07 | LMAT | LEMAITRE VASCULAR INC | Thorndike William N Jr | Director | SELL | $6.00 | 10,600 | $63,611 | 10,929 |
| 2013-03-12 02:29 | 2013-03-11 | DXCM | DEXCOM INC | SKYLER JAY S | Director | BUY | $15.50 | 70,000 | $1,085,000 | 121,975 |
| 2013-03-09 01:30 | 2013-03-06 | PDEX | PRO DEX INC | Swenson Nicholas John | 10% owner | BUY | $2.00 | 25,560 | $51,120 | 560,772 |
| 2013-03-07 20:11 | 2013-03-05 | ATRC | AtriCure, Inc. | Lucky James L | Officer | OPT+S | $8.14 | 50,065 | $407,444 | 51,250 |
| 2013-03-07 01:52 | 2013-03-01 | LMAT | LEMAITRE VASCULAR INC | Thorndike William N Jr | Director | OPT+S | $6.04 | 18,471 | $111,594 | 21,529 |
| 2013-03-06 05:50 | 2013-03-04 | RMD | RESMED INC | Douglas Robert Andrew | Officer | OPT+S | $43.43 | 8,000 | $347,455 | 98,831 |
| 2013-03-05 21:38 | 2013-03-01 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | Director, Officer | OPT+S | $41.06 | 13,000 | $533,811 | 116,286 |
| 2013-03-06 00:07 | 2013-03-01 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | OGRADY JUDITH | Officer | SELL | $40.35 | 1,000 | $40,350 | 22,674 |
| 2013-03-06 00:17 | 2013-02-28 | GBSX | Marizyme Inc. | MOORE JOHN A JR | Director | BUY | $0.30 | 450,960 | $135,288 | 450,960 |
| 2013-03-06 01:27 | 2013-03-01 | PODD | INSULET CORP | DeSisto Duane | Director, Officer | OPT+S | $22.06 | 20,000 | $441,104 | 141,666 |
| 2013-03-06 01:22 | 2013-03-01 | PODD | INSULET CORP | Devlin Peter | Officer | OPT+S | $22.11 | 30,000 | $663,414 | 54,315 |
| 2013-03-06 04:11 | 2013-03-05 | ARAY | Accuray Incorporated | WINGER DENNIS L | Director | BUY | $4.30 | 20,000 | $85,938 | 89,100 |
| 2013-03-06 00:46 | 2013-03-01 | DXCM | DEXCOM INC | GREGG TERRANCE H | Director, Officer | SELL | $14.76 | 9,000 | $132,858 | 823,889 |
| 2013-03-05 00:41 | 2013-03-01 | BAX | BAXTER INTERNATIONAL INC | GAVIN JAMES R III | Director | OPT+S | $68.80 | 10,030 | $690,064 | 19,658 |
| 2013-03-01 18:40 | 2013-02-28 | WST | WEST PHARMACEUTICAL SERVICES INC | GAILEY JOHN R | Officer | OPT+S | $60.38 | 10,000 | $603,794 | 27,504 |
| 2013-03-01 18:06 | 2013-02-28 | WST | WEST PHARMACEUTICAL SERVICES INC | ANDERSON MICHAEL A | Officer | OPT+S | $60.52 | 4,900 | $296,535 | 47,214 |
| 2013-03-01 00:36 | 2013-02-26 | HAE | HAEMONETICS CORP | White Jonathan | Officer | SELL | $40.69 | 3,000 | $122,070 | 0 |
| 2013-03-01 03:06 | 2013-02-26 | DXCM | DEXCOM INC | Pacelli Steven Robert | Officer | OPT+S | $14.98 | 75,000 | $1,123,298 | 166,052 |
| 2013-02-28 04:39 | 2013-02-25 | RMD | RESMED INC | Reiser Anne | Officer | OPT+S | $43.20 | 10,000 | $432,000 | 36,803 |
| 2013-02-27 22:01 | 2013-02-27 | OFIX | Orthofix Medical Inc. | VATERS ROBERT S | Officer | BUY | $35.97 | 3,000 | $107,910 | 65,616 |
| 2013-02-28 04:37 | 2013-02-25 | RMD | RESMED INC | ROBERTS CHRISTOPHER G | Director | SELL | $43.23 | 30,000 | $1,296,924 | 272,400 |
| 2013-02-27 23:27 | 2013-02-26 | CMXI | Nuo Therapeutics, Inc. | JORDEN DAVID EMERSON | Director | BUY | $0.52 | 25,000 | $13,045 | 6,750,000 |
| 2013-02-27 01:21 | 2013-02-22 | CMXI | Nuo Therapeutics, Inc. | Aldagen Holdings, LLC | 10% owner | BUY | $0.55 | 281,819 | $155,000 | 39,967 |
| 2013-02-27 02:11 | 2013-02-22 | CMXI | Nuo Therapeutics, Inc. | Kent Richard S | Director | BUY | $0.55 | 963,637 | $530,000 | 1,233,740 |
| 2013-02-25 18:28 | 2013-02-22 | MMM | 3M CO | Hardgrove Ian F | Officer | SELL | $103.37 | 2,775 | $286,844 | 9,538 |
| 2013-02-25 19:20 | 2013-02-22 | MMM | 3M CO | Lacey Roger HD | Officer | OPT+S | $103.09 | 24,095 | $2,483,978 | 21,748 |
| 2013-02-22 18:32 | 2013-02-21 | MMM | 3M CO | Vale Michael G. | Officer | OPT+S | $102.56 | 6,774 | $694,729 | 633 |
| 2013-02-22 18:26 | 2013-02-20 | MMM | 3M CO | Shin Hak Cheol | Officer | OPT+S | $104.18 | 22,310 | $2,324,153 | 46,961 |
| 2013-02-22 22:09 | 2013-02-22 | CMXI | Nuo Therapeutics, Inc. | ROSENDALE MARTIN P | Director, Officer | BUY | $0.53 | 20,000 | $10,600 | 186,918 |
| 2013-02-22 21:58 | 2013-02-21 | CMXI | Nuo Therapeutics, Inc. | JORDEN DAVID EMERSON | Director | BUY | $0.53 | 50,000 | $26,500 | 6,725,000 |
| 2013-02-21 18:39 | 2013-02-20 | MMM | 3M CO | Holmes Christopher D | Officer | SELL | $104.22 | 1,400 | $145,901 | 1,146 |
| 2013-02-21 19:07 | 2013-02-20 | MMM | 3M CO | Kelly Michael A | Officer | OPT+S | $104.16 | 10,056 | $1,047,427 | 19,314 |
| 2013-02-21 18:27 | 2013-02-19 | MMM | 3M CO | SAUER BRAD T | Officer | OPT+S | $104.25 | 300 | $31,274 | 21,023 |
| 2013-02-21 18:11 | 2013-02-19 | MMM | 3M CO | SAUER BRAD T | Officer | OPT+S | $104.22 | 29,686 | $3,093,946 | 21,323 |
| 2013-02-21 18:06 | 2013-02-19 | MMM | 3M CO | SAUER BRAD T | Officer | OPT+S | $104.22 | 12,806 | $1,334,600 | 34,453 |
| 2013-02-22 00:39 | 2013-02-19 | CMXI | Nuo Therapeutics, Inc. | DEL GUERCIO JOSEPH | Director | BUY | $0.55 | 509,091 | $280,000 | 1,143,770 |
| 2013-02-21 20:50 | 2013-02-20 | BDX | BECTON DICKINSON & CO | FORLENZA VINCENT A | Director, Officer | OPT+S | $87.92 | 26,000 | $2,285,920 | 108,724 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Surgical & Medical Instruments & Apparatus
Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.